Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Layton BioScience, Inc.
Sunnyvale, California, United Statesprofiles.biocentury.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Layton BioScience, Inc. was a California-based biotechnology company founded in 1991 that focused on developing therapeutics for neurological diseases using neural stem cell technology and small molecule drug combinations. Its most advanced program combined citalopram hydrobromide with mecamylamine hydrochloride targeting ADHD but was discontinued. The company also published research on neural stem cell differentiation and transplantation in animal models of Parkinson’s disease. The company appears to have ceased operations and has no active pipeline or commercial products.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Neural stem cellsSmall molecules (Citalopram Hydrobromide/Mecamylamine Hydrochloride)
- Industry
- Biotech
02
Partnerships
Originator organization for the main drug candidate was University of South Florida.
Beyond the preview
Go deeper on Layton BioScience, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Layton BioScience, Inc..